Evidence for a nonprolactin, non-growth-hormone mammary mitogen in the human pituitary gland
- PMID: 3479780
- PMCID: PMC299488
- DOI: 10.1073/pnas.84.22.8110
Evidence for a nonprolactin, non-growth-hormone mammary mitogen in the human pituitary gland
Abstract
To determine whether the human pituitary contains a previously unidentified, nonprolactin (non-hPRL), non-growth-hormone (non-hGH) factor capable of stimulating mammary development, we tested the effects of whole human pituitary extract (hPE) and pituitary extracts depleted of hPRL and hGH ("stripped hPE") in hypophysectomized, castrated estradiol (E2)-treated male rats and rhesus monkeys. Both whole and stripped hPE significantly stimulated rat mammary development (mean scores = 3.3 and 2.0, respectively, on a scale ranging from 0 to 4) in comparison with controls (mean score = 1.0). Mammary development was not due to minute concentrations of hGH or hPRL remaining in stripped hPE because 30- to 100-fold higher concentrations of hGH (Genentech) and 1000-fold higher concentrations of hPRL were required to stimulate significant mammary development. Non-pituitary extracts of human ovary, muscle, and serum, and bovine serum albumin did not stimulate rat mammary gland growth. Trypsin destroyed the mammary mitogenic activity of whole hPE, indicating that the unidentified factor is likely a protein. Mammary growth and development were also stimulated in hypophysectomized, E2-treated monkeys by stripped hPE (mean histological score = 3.25 vs. 1.35 in control animals). Monkeys receiving stripped hPE had undetectable levels of hGH and hPRL in serum sampled over a 24-hr period. These findings suggest that the human pituitary contains a non-hPRL, non-hGH factor that stimulates mammary growth and may be important in normal mammary growth and development and perhaps in breast cancer.
Similar articles
-
Primate mammary development. Effects of hypophysectomy, prolactin inhibition, and growth hormone administration.J Clin Invest. 1985 Jun;75(6):1943-50. doi: 10.1172/JCI111910. J Clin Invest. 1985. PMID: 4008646 Free PMC article.
-
Estradiol enhances the stimulatory effect of insulin-like growth factor-I (IGF-I) on mammary development and growth hormone-induced IGF-I messenger ribonucleic acid.Endocrinology. 1995 Mar;136(3):1296-302. doi: 10.1210/endo.136.3.7867584. Endocrinology. 1995. PMID: 7867584
-
The ontogenesis of human fetal hormones. III. Prolactin.J Clin Invest. 1975 Jul;56(1):155-64. doi: 10.1172/JCI108064. J Clin Invest. 1975. PMID: 1141430 Free PMC article.
-
Improving the pharmacokinetics/pharmacodynamics of prolactin, GH, and their antagonists by fusion to a synthetic albumin-binding peptide.J Endocrinol. 2009 Dec;203(3):375-87. doi: 10.1677/JOE-09-0211. Epub 2009 Sep 21. J Endocrinol. 2009. PMID: 19770179
-
Prolactin and breast carcinoma.N Engl J Med. 1975 Apr 10;292(15):784-92. doi: 10.1056/NEJM197504102921506. N Engl J Med. 1975. PMID: 1089886 Review.
Cited by
-
Intact and amino-terminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development.Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10872-6. doi: 10.1073/pnas.89.22.10872. Proc Natl Acad Sci U S A. 1992. PMID: 1438291 Free PMC article.
-
The role of hormones, growth factors and their receptors in pituitary tumorigenesis.Brain Pathol. 2001 Jul;11(3):356-70. doi: 10.1111/j.1750-3639.2001.tb00405.x. Brain Pathol. 2001. PMID: 11414477 Free PMC article. Review.
-
The role of growth factors in the pituitary.J Endocrinol Invest. 1990 Sep;13(8):691-8. doi: 10.1007/BF03349601. J Endocrinol Invest. 1990. PMID: 2273213 Review. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources